NEW YORK, Sept. 24, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ServiceTitan, Inc. ("ServiceTitan" or the "Company") (NASDAQ: TTAN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

The investigation concerns whether ServiceTitan and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

[Click here for information about joining the class action]

On September 8, 2026, ServiceTitan reported second quarter 2027 earnings. Among other items, the Company reported that "[b]ecause Max" – ServiceTitan's AI-powered enterprise software package – "requires substantial change management, we typically do not bill subscription fees for the first quarter of an upsell Max contract, and we have also elected not to charge existing customers an onboarding fee when transitioning to Max. As a result of these factors, we expect both our platform revenue and professional services revenue to grow at a slower pace for the remainder of fiscal 2027." The Company further reported that "[w]e expect the mix shift to Max to lower professional services revenue by roughly an additional $2 million over the remainder of this fiscal year, which, of course, also flows through to professional services gross margin."

On this news, ServiceTitan's stock price fell $24.46 per share, or 29.98%, to close at $57.12 per share on September 9, 2026.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Danielle Peyton

Pomerantz LLP

[email protected]

646-581-9980 ext. 7980

SOURCE Pomerantz LLP

Share this article

PUNE, India, Sept. 24, 2026 /PRNewswire/ -- The Global Bioinformatics Market was valued at USD 20.34 Billion in 2025 and is projected to expand at a 13.7% CAGR from 2026 to 2034, reaching USD 64.60 Billion by 2034, according to a new analysis by Maximize Market Research.

Global Bioinformatics Market

The Global Bioinformatics Market Report 2025 provides a comprehensive analysis of market trends, genomic data generation, next-generation sequencing (NGS), bioinformatics platforms, bioinformatics services, knowledge management tools, computational biology, biological databases, technology adoption, deployment models, application areas, end-user sectors, research activities, competitive developments, and market forecasts through 2034. The market covers genomics, proteomics, transcriptomics, metabolomics, molecular phylogenetics, chemoinformatics, and other bioinformatics applications across sequencing technology, microarray technology, mass spectrometry, high-throughput screening, data mining and machine learning, and structural bioinformatics tools.

The increasing volume of genomic and biological data, growing adoption of next-generation sequencing, expansion of precision medicine, rising pharmaceutical and biotechnology R&D, increasing demand for genomic data analysis, and broader application of computational biology are supporting the growth of the global bioinformatics market. Growing adoption of bioinformatics platforms, cloud-based bioinformatics, biological databases, data mining, machine learning, and AI-enabled analytical solutions is transforming genomics, drug discovery, molecular diagnostics, personalized medicine, and life-science research. Increasing investments in genomic research, sequencing infrastructure, biotechnology, pharmaceutical R&D, and computational technologies are further expanding opportunities for bioinformatics solution providers.

Advancements in artificial intelligence, machine learning, cloud computing, high-performance computing, genomic sequencing, biological data integration, data analytics, molecular modeling, and computational drug discovery are reshaping the bioinformatics landscape. Increasing research across genomics, proteomics, transcriptomics, metabolomics, chemoinformatics, and molecular phylogenetics is creating new opportunities for pharmaceutical and biotechnology companies, academic and research institutes, healthcare providers, and agricultural biotechnology organizations. Platform development, software innovation, strategic collaborations, genomic research initiatives, technology investments, data-management capabilities, and expansion of cloud-based bioinformatics solutions are expected to accelerate innovation and strengthen the global bioinformatics market through 2034.

Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @https://www.maximizemarketresearch.com/request-sample/207971/

Global Bioinformatics Market gains momentum as rising genomic data generation, increasing adoption of next-generation sequencing, growing demand for precision medicine, rapid integration of AI and machine learning, expansion of cloud-based bioinformatics, and advances in computational biology and genomic data analytics accelerate innovation: Maximize Market Research unveils key market insights.

Global Bioinformatics Market Size & Forecast

Global Bioinformatics Market Trends & Insights

- North America leads the Global Bioinformatics Market, supported by advanced pharmaceutical and biotechnology R&D, strong genomics infrastructure, high adoption of next-generation sequencing, precision medicine, and advanced bioinformatics platforms.

- Asia Pacific is the fastest-growing region, driven by expanding biotechnology and pharmaceutical industries, increasing genomic sequencing, healthcare digitization, investments in precision medicine, and rising adoption of cloud-based bioinformatics and computational tools.

- Genomics and next-generation sequencing are driving market demand, as the growing volume of genomic data increases the need for advanced sequencing analysis, biological databases, data mining, computational biology, and genomic data interpretation.

- AI, machine learning, and cloud computing are transforming bioinformatics, enabling faster biological data processing, predictive analytics, molecular analysis, automated workflows, drug discovery, and scalable genomic research across pharmaceutical, biotechnology, and academic institutions.

- Precision medicine and personalized healthcare are accelerating bioinformatics adoption, with increasing demand for pharmacogenomics, biomarker analysis, genomic diagnostics, molecular profiling, and computational approaches that support targeted therapies and data-driven drug development.

Bioinformatics Market Dynamics

Growing Genomic Data Generation and NGS Drives Market Growth

The increasing adoption of next-generation sequencing (NGS) is generating large volumes of genomic data, driving demand for bioinformatics platforms, sequencing data analysis, biological databases, and computational biology. Growing applications in genomics, precision medicine, molecular diagnostics, drug discovery, and pharmacogenomics are further supporting market growth. The declining cost of sequencing and expansion of sequencing capabilities are encouraging more research institutions, pharmaceutical companies, and biotechnology organizations to adopt advanced bioinformatics solutions. Increasing genomic research and the need for faster interpretation of complex biological datasets are also strengthening demand for computational tools.

High Infrastructure Costs and Data Security Concerns Restrain Market Growth

High costs associated with high-performance computing, specialized software, data storage, cloud infrastructure, and skilled professionals can limit bioinformatics adoption, particularly among smaller research organizations. Concerns surrounding genomic data privacy, cybersecurity, regulatory compliance, and interoperability also remain important market restraints. Managing large biological datasets requires secure and scalable infrastructure, increasing operational and technology requirements. Differences between databases and bioinformatics platforms can further create challenges in seamless data sharing and integration.

AI and Cloud-Based Bioinformatics Create Opportunities

Integration of AI, machine learning, cloud computing, data mining, predictive analytics, and automated workflows is creating new opportunities in genomic data analysis, drug discovery, biomarker identification, and molecular research. Cloud-based platforms provide scalable solutions for processing large biological datasets while reducing the need for extensive on-premise computing infrastructure. AI-driven tools can support genome interpretation, protein analysis, molecular modeling, sequence analysis, and computational drug discovery. Growing adoption of these technologies across pharmaceutical, biotechnology, healthcare, and academic research is expected to expand the application scope of bioinformatics.

Shortage of Skilled Professionals Creates Challenges

The growing complexity of genomic datasets, biological databases, sequencing technologies, computational algorithms, and analytical workflows is increasing demand for specialized bioinformatics professionals. Shortages of skilled talent with expertise across biology, computer science, statistics, data science, and molecular biology can restrict the efficient implementation of advanced solutions. Data standardization, interoperability, and integration challenges can also complicate the management of biological information across multiple platforms. These limitations may affect organizations seeking to establish large-scale bioinformatics infrastructure, genomic data analysis systems, and computational research capabilities.

Get Insightful Data on Regions, Market Segments, Customer Landscape, and Top Companies (Charts, Tables, Figures and More) https://www.maximizemarketresearch.com/request-sample/207971/

Global Bioinformatics Market Segmentation

The Global Bioinformatics Market is segmented by Product and Services, Technology, Deployment Model, Database Type, Application, End User Sector, and Region. Increasing genomic data generation, growing adoption of next-generation sequencing, rising demand for computational biology, AI and machine learning integration, expansion of cloud-based platforms, and increasing applications in precision medicine and drug discovery are supporting market development across these segments.

North America Leads the Bioinformatics Market While Asia Pacific Emerges as a High-Growth Region

North America held the largest share of the Global Bioinformatics Market in 2025, supported by strong pharmaceutical and biotechnology R&D, advanced genomics infrastructure, high adoption of next-generation sequencing (NGS), precision medicine, and computational biology. The United States represents a major market due to its established biotechnology ecosystem, genomic research capabilities, academic institutions, and adoption of bioinformatics platforms, biological databases, AI-driven analytics, and cloud-based bioinformatics solutions. Canada and Mexico are also contributing through expanding biotechnology activities, genomic research, and healthcare digitization.

Europe represents an important market, supported by established pharmaceutical and biotechnology industries, strong research institutions, advanced healthcare infrastructure, and increasing investment in genomics, proteomics, molecular diagnostics, and personalized medicine. Germany, the United Kingdom, France, Italy, Spain, Sweden, Austria, and other European countries are witnessing increasing adoption of bioinformatics software, sequencing data analysis, biological databases, computational biology, and AI-based research tools. Growth in genomic research and precision medicine is further supporting regional development.

Federal award will make CenterPoint one of the first U.S. utilities to deploy industry-leading substation technology to enhance resiliency, reliability and respond to increases in energy demand.

HOUSTON, Sept. 24, 2026 /PRNewswire/ -- Today, the U.S. Department of Energy (DOE) and Assistant Secretary for the DOE's Office of Electricity Katie Jereza announced the selection of CenterPoint Energy for a $50 million award to support advanced substation technology upgrades. Following finalization of negotiations with DOE, this award will help fund and support CenterPoint Energy's ongoing efforts to strengthen electric reliability and resiliency and increase energy capacity for one of the fastest growing regions in Texas and the nation.

"Our mission is to build the most resilient coastal grid in the nation for the 2.9 million customers we proudly serve in the Greater Houston area, and we're grateful to the DOE for this vital investment in both Houston's and Texas's energy infrastructure. This selection is historic for our region, and it will directly fund industry-leading technology improvements that are expected to strengthen resiliency, reliability and meet the growing energy needs of our region," said Jason Ryan, CenterPoint Energy's Executive Vice President, Regulatory Services & Government Affairs.

Historic Energy Infrastructure Investment: Critical Substation Improvements

With the DOE project, CenterPoint Energy will become one of the first utilities in the nation to install Siemens Energy's industry-leading, transmission grid stabilizing technology, which can respond rapidly to changes in electricity demand and help maintain reliable service for local customers. The key expected benefits from this advanced technology project include:

- Strengthening resiliency and reliability during periods of high demand;

- Increasing capacity to meet current and future demand and economic growth;

- Expected to create more than 500 local jobs to support project construction and installation.

The funding will prove critical to the region's energy future and was selected through DOE's Speed to Power through Accelerated Reconductoring and other Key Advanced Transmission Technology Upgrades (SPARK) program. The SPARK Program supports projects that modernize existing electrical infrastructure and help ensure our nation's utilities reliably meet growing energy demand and lower electricity costs for approximately 100 million Americans.

"Through the SPARK program, we are investing in vital projects across the country that expand energy grid capacity, strengthen reliability and resiliency, and support the economic development of communities. The Department of Energy is proud to support forward-looking infrastructure improvements that will help power growth and dependable energy for the Houston area," said Katie Jereza, Assistant Secretary, U.S. Department of Energy's Office of Electricity.

"Generations of CenterPoint customers and families in the region will benefit from the advanced technology this grant is funding," said Commissioner Kathleen Jackson, Public Utility Commissioner of Texas. "And anytime companies make improvements like this to their systems, the long-term impact is making the entire grid stronger for Texans."

To learn more about CenterPoint Energy's resiliency and reliability improvements across Greater Houston, please visit CenterPointEnergy.com/Progress.

About CenterPoint Energy, Inc.

As the only investor owned electric and gas utility based in Texas, CenterPoint Energy, Inc. (NYSE: CNP) is an energy delivery company with electric transmission and distribution, power generation and natural gas distribution operations that serve more than 7 million metered customers in Indiana, Minnesota and Texas. As of June 30, 2026, the company owned approximately $48.3 billion in assets. With approximately 8,800 employees, CenterPoint Energy and its predecessor companies have been in business for more than 150 years. For more information, visit CenterPointEnergy.com.

Forward-Looking Statement

This news release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based upon assumptions of management which are believed to be reasonable at the time made and are subject to significant risks and uncertainties. Actual events and results may differ materially from those expressed or implied by these forward-looking statements. Any statements in this news release regarding future events, such as the implementation of advanced substation technology upgrades and the benefits therefrom (including jobs creation), the reliability and resiliency of the electric grid, and any other statements that are not historical facts are forward-looking statements. Each forward-looking statement contained in this news release speaks only as of the date of this release. Important factors that could cause actual results to differ materially from those indicated by the provided forward-looking information include risks and uncertainties relating to: (1) business strategies and strategic initiatives involving CenterPoint Energy or its industry; (2) CenterPoint Energy's ability to fund and invest planned capital, and the timely recovery of its investments; (3) financial market and general economic conditions; (4) the timing and impact of future regulatory, legislative and political actions or developments; and (5) other factors, risks and uncertainties discussed in CenterPoint Energy's Annual Report on Form 10-K for the fiscal year ended December 31, 2025 and CenterPoint's Quarterly Report on Form 10-Q for the quarters ended March 31, 2026 and June 30, 2026 and other reports CenterPoint Energy or its subsidiaries may file from time to time with the Securities and Exchange Commission.

For more information, contact:

Communications

[email protected]

SOURCE CenterPoint Energy

Share this article

NEW YORK, Sept. 24, 2026 /PRNewswire/ -- Today, the N7 Foundation convened a high-level roundtable, chaired by N7 Chairman Jeffrey M. Talpins, with U.S. Under Secretary of State Allison Hooker and her counterparts from the Kingdom of Bahrain, the State of Israel, the Republic of Kazakhstan, the Kingdom of Morocco, and the United Arab Emirates, to discuss the future of the Abraham Accords and opportunities to deepen regional cooperation. The N7 roundtable is the first meeting of the Accords countries since January 2023, and the first official engagement to include Kazakhstan.

Officials reaffirmed the principles of the Abraham Accords and recognized that the Middle East's vast potential can be unlocked through coexistence, mutual understanding, and cooperation between Israel, its Arab and Muslim neighbors, the United States, and likeminded partners. Officials welcomed Kazakhstan's forthcoming ascension to the Accords and stressed the importance of tangible outcomes on shared priorities, noting that such cooperation can promote regional stability and security and provide a platform for peace and prosperity.

"The Abraham Accords have demonstrated what is possible when countries come together around shared interests with a common vision for a more integrated and prosperous region," said Mr. Jeffrey M. Talpins, Chairman & Founder of the N7 Foundation. "The next phase is about deepening the relationships that already exist and identifying practical opportunities for countries to work together. The N7 Foundation is committed to advancing this future and transforming the Abraham Accords into a forum for strategic, regional cooperation."

"The Abraham Accords have created a foundation for a more connected region, and their full potential will be realized through the practical cooperation they make possible," said Oren Eisner, President of the N7 Foundation. "Today's discussion focused on the work ahead: strengthening existing relationships, welcoming new partners, and advancing initiatives that deliver tangible benefits to people and economies across the region."

Building on its historic role hosting the first ever multilateral convening of the Accords countries in 2021, the N7 Foundation will continue to work with Accords countries and aligned partners to further develop the next chapter of the Accords, with an emphasis on deepening and expanding cooperation and transforming shared interests into concrete benefits for all members. The N7 Foundation will explore durable mechanisms for strategic, multilateral cooperation that can elevate partnership through the Accords. This, we believe, can help cultivate a future for the region that is more stable, secure, integrated, prosperous, and interconnected with the world.

About the N7 Foundation:

The N7 Foundation is a nonpartisan policy development and convening platform dedicated to strengthening and broadening relations among the United States, Israel, and Arab and Muslim countries. Our efforts are guided by our principal belief that enhanced cooperation among these countries will generate significant benefits to the region and advance strategic U.S. interests. We believe in the power and potential of a more peaceful, secure, integrated Middle East, interconnected with the world.

Contact: [email protected]

SOURCE N7 Foundation

Share this article

New Cox Automotive research finds 63% of vehicle shoppers plan to use AI, while only 29% of dealers say they are adjusting for AI-powered search

SAN ANTONIO, Sept. 24, 2026 /PRNewswire/ -- CarLocal.io is expanding its automotive AI answer engine and dealership visibility infrastructure as artificial intelligence becomes a more important starting point in the vehicle-shopping journey.

The shift is already showing up in industry research. According to Cox Automotive's Q2 2026 AI in Auto Retail Tracker, 63% of in-market vehicle shoppers say they definitely or probably will use AI during their next vehicle purchase. AI tools are now used as a vehicle research channel by 36% of shoppers, nearly level with automotive-specific websites at 38%.

Dealer adoption, however, has not moved at the same pace. Cox reports that only 29% of dealers say they are actively adjusting or in the process of adjusting for AI-powered search.

That creates a new challenge for automotive retailers: When a shopper asks an AI platform what vehicle to buy, where to buy it, how much it should cost or where to have it serviced, will that dealership be part of the answer?

"The biggest change isn't simply that consumers are using AI," said Chris J. Martinez, founder of CarLocal.io. "It's that the starting point of the shopping journey can now be a question instead of a traditional search. Dealers have spent years competing to rank on Google. The next challenge is making sure their dealership, inventory and local expertise can be understood and surfaced when consumers ask AI for an answer."

CarLocal.io is building around that shift.

The platform combines automotive AI search, answer engine optimization (AEO), generative engine optimization (GEO), structured dealership information, local automotive intent coverage and technical website infrastructure designed to make dealership information easier for search engines and AI systems to discover, interpret and connect.

The consumer-facing CarLocal experience is being developed to answer natural-language automotive questions, while the underlying infrastructure helps organize and connect dealership information across traditional search, answer engines and emerging AI interfaces.

The goal is straightforward: help local dealerships become part of the answer as automotive discovery moves from searching to asking.

How Vehicle Discovery Is Changing

The change is visible in the types of questions consumers can now ask conversational systems. Instead of searching only for a dealership or vehicle model, a shopper can ask which three-row SUV fits a specific budget, whether leasing or financing makes more sense for a particular situation, what to consider before buying a used electric vehicle, or where to service a vehicle locally.

Cox Automotive reported that among shoppers using AI, 26% use it to generate questions to ask dealers and 24% say it helps them feel more prepared when working with a dealership. Avoiding dealership staff was the least-cited dealer-relationship benefit at 17%, suggesting AI is often being used to prepare for the dealership interaction rather than eliminate it.

"The important change is not simply that consumers are using AI," said Chris J. Martinez, founder of CarLocal.io. "It is that the starting point can now be a question instead of a website. That changes what information needs to be available, how it needs to be structured and how a local dealership can become part of the answer."

What CarLocal Is Building

CarLocal is developing an automotive AI answer engine and dealership visibility platform around the shift from keyword search toward conversational discovery. The consumer-facing experience is designed to address natural-language automotive questions, while the underlying infrastructure organizes dealership information so it can be more readily interpreted across traditional search, answer engines and emerging AI interfaces.

What CarLocal Is Finding on Dealership Websites

CarLocal's internal analysis of automotive retail websites has identified recurring technical and content issues that can complicate machine discovery. These include orphaned content with weak or missing internal pathways, conflicting canonical signals, sitemap gaps, inconsistent dealership information and promotional language that cannot be tied to a current verified offer.

In a recent quality initiative across CarLocal's dealership network, the platform corrected more than 11,000 promotional claims, removed more than 23,000 unsupported promotional references from page content and resolved 573 canonical conflicts. CarLocal also applied more than 68,000 internal links to strengthen connections between automotive content and reduce orphaned pages.

These figures are internal operational findings from CarLocal's platform work, not an independent industry sample. They are included to show the types and scale of issues CarLocal has encountered within the dealership websites it currently supports and should not be generalized to all U.S. dealerships.

How CarLocal Is Responding

The platform combines traditional search-engine fundamentals with answer engine optimization (AEO), generative engine optimization (GEO), structured dealership information and local automotive intent coverage. CarLocal is also developing MCP-ready infrastructure around the Model Context Protocol, an open standard for connecting AI applications with external data sources and tools.

Within CarLocal's architecture, MCP is one component intended to prepare dealership information for a future in which AI assistants and agents may retrieve information, use external tools and help consumers move from research toward action through conversational interfaces. The consumer sees an answer; underneath it is an information layer intended to organize automotive knowledge and connect consumer intent with relevant local resources.

CarLocal separately evaluates whether content is technically accessible, whether it meets internal quality requirements and whether visibility can actually be observed. Publishing or analyzing a page is not counted as proof that an external search engine or AI system has surfaced it.

CarLocal.io Platform Metrics

As of September 2026, CarLocal supports 21 active dealership deployments and has analyzed more than 49,000 live automotive web pages. These figures describe platform deployment and technical analysis activity; they are not presented as independent evidence of consumer adoption, search-ranking gains or AI citation performance.

The quality initiative figures cited above are also internal operational counts. CarLocal reports them separately from third-party market research so readers can distinguish external consumer and dealer trends from observations generated through CarLocal's own platform.

Methodology and Sources

The consumer and dealer market statistics in this release come from Cox Automotive's AI in Auto Retail Tracker. Cox reports that its Q2 2026 wave surveyed 483 franchise and independent dealership decision-makers and 1,502 consumers planning to purchase a vehicle within the next 12 months. The Q2 surveys were fielded in May 2026, and dealership data were weighted by dealership size.

CarLocal platform figures are internal operational counts as of September 2026. They reflect active dealership deployments and pages processed or analyzed by CarLocal systems. They are provided for scale and product context and should not be interpreted as third-party market research.

Sources

Cox Automotive, AI in Auto Retail Tracker (Q1–Q2 2026): https://www.coxautoinc.com/retail/ai-in-auto-retail-tracker/

Cox Automotive, "New Cox Automotive AI in Auto Retail Tracker Finds Growing Gap Between Dealers and AI-Powered Car Shoppers," Aug. 11, 2026: https://www.coxautoinc.com/press-releases/new-cox-automotive-ai-in-auto-retail-tracker/

Cox Automotive, "How AI Is Influencing Vehicle Discovery and What Dealers Can Do About It," Aug. 26, 2026: https://www.coxautoinc.com/insights/how-ai-is-influencing-vehicle-discovery-and-what-dealers-can-do-about-it/

About CarLocal.io

CarLocal.io is an automotive AI answer engine and search visibility platform focused on helping consumers navigate vehicle research and ownership questions while helping local dealerships make accurate information more discoverable across traditional search, answer engines and generative AI. Its technology includes dealership website analysis, AEO, GEO, structured information, local intent coverage, content quality controls and MCP-ready infrastructure.

SOURCE CarLocal

Share this article

ATLANTA, Sept. 24, 2026 /PRNewswire/ -- Delta Air Lines' (NYSE:DAL) Board of Directors today declared a quarterly dividend of $0.2150 per share. The dividend is payable to shareholders of record as of the close of business on October 15, 2026, and will be paid on November 5, 2026.

About Delta

No one better connects the world

Through exceptional service and the power of innovation, Delta Air Lines (NYSE: DAL) never stops looking for ways to make every trip feel tailored to every customer.

There are 100,000 Delta people leading the way to deliver a world-class customer experience on up to 5,500 daily Delta and Delta Connection flights to more than 300 destinations on six continents, connecting people to places and to each other.

Delta served more than 200 million customers in 2025 – safely, reliably and with industry-leading customer service innovation – and was recognized by J.D. Power in 2025 for being No. 1 in Premium Economy Passenger Satisfaction. The airline also was recognized by Cirium as North America's most on-time airline in 2025.

We remain committed to ensuring that the future of travel is connected, personalized and enjoyable. Our people's genuine, enduring motivation is to make every customer feel welcomed and cared for across every point of their journey with us.

SOURCE Delta Air Lines

Share this article

RESTON, Va., Sept. 24, 2026 /PRNewswire/ -- ICF (NASDAQ:ICFI), a leading global solutions and technology provider, will release its third quarter 2026 results on Thursday, November 5, 2026, after the market close.

The Company plans to host a webcast call at 4:30 p.m. Eastern time on Thursday, November 5, 2026, to discuss its financial results for the quarter. Earnings results will be available at https://investor.icf.com before the call.

Call Access Process

Analysts and institutional investors may actively participate by registering online at https://register-conf.media-server.com/register/BI8f18d40afff846bb9db190b4233f0da3. Once registered, participants will receive dial-in information and a unique PIN to access the call as well as an email confirmation with the details.

General listeners can access the live webcast at https://edge.media-server.com/mmc/p/273vq66x.

A replay of the webcast will be available for one year following the live event at https://investor.icf.com/news-events.

For More Information

Investor information contact:

Lynn Morgen, AdvisIRy Partners, [email protected], +1.212.750.5800

or

David Gold, AdvisIRy Partners, [email protected], +1.212.750.5800

Company information contact:

Lauren Dyke, ICF, [email protected], +1.571.373.5577

About ICFS

ICF (NASDAQ:ICFI) is a leading global solutions and technology provider. At ICF, business analysts and policy specialists work together with digital strategists, data scientists and creatives. We combine unmatched industry expertise with cutting-edge engagement capabilities to help organizations solve their most complex challenges. Since 1969, public and private sector clients have worked with ICF to navigate change and shape the future. Learn more at icf.com.

Caution Concerning Forward-looking Statements

Statements that are not historical facts and involve known and unknown risks and uncertainties are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995, as amended. Such statements may concern our current expectations about our future results, plans, operations and prospects and involve certain risks, including those related to: the government contracting industry generally; our dependence on contracts with U.S. federal, state and local, and international government clients for the majority of our revenue; failure by Congress or other governmental bodies to approve budgets and appropriations in a timely fashion, reductions in government spending, and the impact of a lengthy federal government shutdown; the current Administration's policy changes, executive orders, and failure to spend Congressionally mandated appropriations, including the resulting effect on government audits and contract terminations; changes in federal government budgeting and spending priorities; our ability to estimate and control costs under our fixed-price contracts; the realization of our backlog; the dependence of our commercial work on sectors of the global economy that are highly cyclical; and our ability to acquire and successfully integrate businesses. These and other factors that could cause our actual results to differ materially from those indicated in our forward-looking statements are described in the "Risk Factors" section of our Annual Report on Form 10-K for the year ended December 31, 2025, and in our subsequent filings with the Securities and Exchange Commission. The forward-looking statements included herein are made only as of the date hereof, and we specifically disclaim any obligation to update these statements in the future.

SOURCE ICF

Share this article

The board of directors today declared a quarterly dividend of $0.2775 per share on the company's common shares, payable Nov. 2, 2026.

Key Takeaways:

- The board of directors declared a quarterly dividend of $0.2775 per share on the company's common shares.

- Dividends on common stock as well as Series A and Series C preferred stock are payable on Nov. 2, 2026.

DALLAS, Sept. 24, 2026 /PRNewswire/ -- The board of directors of AT&T (NYSE:T) today declared a quarterly dividend of $0.2775 per share on the company's common shares.

The board of directors also declared quarterly dividends on the company's 5.000% Perpetual Preferred Stock, Series A and the company's 4.750% Perpetual Preferred Stock, Series C. The Series A dividend is $312.50 per preferred share, or $0.3125 per depositary share. The Series C dividend is $296.875 per preferred share, or $0.296875 per depositary share.

Dividends on the common stock and Series A and Series C preferred stock are payable on Nov. 2, 2026, to stockholders of record of the respective shares at the close of business on Oct. 12, 2026.

To automatically receive AT&T financial news by email, please subscribe to email alerts.

About AT&T

We help more than 100 million U.S. families, friends and neighbors, plus nearly 2.5 million businesses, connect to greater possibility. From the first phone call 150+ years ago to our 5G wireless and multi-gig internet offerings today, we @ATT innovate to improve lives. For more information about AT&T Inc. (NYSE:T), please visit us at about.att.com. Investors can learn more at investors.att.com.

SOURCE AT&T

Share this article

Webcast and conference call on October 30 at 7 a.m. PT (10 a.m. ET)

SEATTLE, Sept. 24, 2026 /PRNewswire/ -- Weyerhaeuser Company (NYSE: WY) will release third quarter 2026 results on Thursday, October 29, after the market closes. The company will then hold a live webcast and conference call the following day, on Friday, October 30, at 7 a.m. Pacific (10 a.m. Eastern), to discuss the results.

To access the earnings release, live webcast and presentation online, visit the Investors section on www.weyerhaeuser.com.

To join the conference call from within North America, dial 877-407-0792 (access code: 13755109) at least 15 minutes prior to the call. Those calling from outside North America should dial 201-689-8263 (access code: 13755109). Replays will be available for two weeks at 844-512-2921 (access code: 13755109) from within North America, and at 412-317-6671 (access code: 13755109) from outside North America.

ABOUT WEYERHAEUSER

Weyerhaeuser Company, one of the world's largest private owners of timberlands, began operations in 1900 and today owns or controls more than 10 million acres of timberlands in the U.S., as well as additional public timberlands managed under long-term licenses in Canada. Weyerhaeuser has been a global leader in sustainability for more than a century and manages 100 percent of its timberlands on a fully sustainable basis in compliance with internationally recognized sustainable forestry standards. Weyerhaeuser is also one of the largest manufacturers of wood products in North America and operates additional business lines around product distribution, climate solutions, real estate, and energy and natural resources, among others. In 2025, the company generated $6.9 billion in net sales and employed approximately 9,500 people who serve customers worldwide. Operated as a real estate investment trust, Weyerhaeuser's common stock trades on the New York Stock Exchange under the symbol WY. Learn more at www.weyerhaeuser.com.

For more information contact:

Analysts - Andy Taylor, 206-539-3907

Media – Nancy Thompson, 919-861-0342

SOURCE Weyerhaeuser Company

Share this article

$50 million gift promises to further advance CSF Leak Program's patient access, research and innovation

AURORA, Colo., Sept. 24, 2026 /PRNewswire/ -- On an early summer day in 2017, Jen MacKenzie's busy and fulfilling life as a wife and homeschool mom suddenly began to slip away. She woke up with what felt like severe jet lag – a headache and profound fatigue. Within a couple of months, she was engulfed by other symptoms that left her sidelined from a normal active life: nausea, dizziness, brain fog and hyper-sensitivity to sounds.

"For me, it was a very specific onset. It felt like I was in quicksand," said the mother of two children, then ages 8 and 12. "I was grounded from daily life."

Jen's debilitating symptoms gradually robbed her of her ability to cook, drive and do most daily activities. The headache felt like a warm brick at the base of her skull. "It wasn't a headache in the commonly understood sense," she said. "It was weighted and warm, and deeply unsettling to experience."

Meanwhile, she described the dysfunction of her sensory systems as its own kind of pain. "It's really disorienting," she said. "It just felt like there were lots of aspects of pain and dysfunction that were happening simultaneously."

Why CSF leaks can take years to diagnose

During those first years, she saw her primary physician and specialists, including multiple neurologists, getting diagnosed with migraine, new daily persistent headache, cervicogenic headache, medication-overuse headache, temporomandibular dysfunction and other conditions. "None of the treatments did anything to provide relief or reduce the head pain," said Jen, who lives in Washington state.

She steadfastly explained to doctors what her life was like before the quicksand. "Honestly, I felt like I was going crazy, but I tried to trust that I knew what I was experiencing."

Almost exactly two years after onset, a primary physician suggested she might have a CSF leak, having seen a patient with similar symptoms a few years earlier. That prompted her to seek care specific to CSF leaks, including specialists out of state.

Her difficult journey continued for 5-1/2 years – "flat on my back staring at the ceiling" (with increased headache pain when standing a hallmark of CSF leaks) – before Jen learned of Andrew Callen, MD, and the Cerebrospinal Fluid (CSF) Leak Program at the CU Anschutz School of Medicine.

She vividly remembers the phone call in which Callen quietly listened and said, "I'm happy to help." It was the moment Jen began to reclaim her life.

How a $50M gift will expand CSF leak care and research

Cerebrospinal fluid surrounds and protects the brain and spinal cord. When that fluid leaks, the resulting pressure changes can cause headaches and other neurological symptoms.

In just a few years, CU Anschutz has grown into one of the nation's leading centers for CSF leak diagnosis and treatment. Callen's team performs about 20 CSF leak procedures a week, totaling close to 600 a year, with approximately 50% of patients being out of network, out of state and even out of country, he said. "There just aren't enough places doing this work, so people have to find somewhere to go."

Callen said the landmark gift of $50 million from an anonymous donor will help "supercharge" the CSF Leak Program's patient access, research, innovation and overall impact for this undertreated and underdiagnosed illness.

What is a CSF leak?

Cerebrospinal fluid is a clear liquid that surrounds the brain and spinal cord. It serves as a shock absorber to cushion the brain and spinal cord from sudden impact or injury, also making the brain feel lighter and keeping lower structures from being crushed by their own weight. It carries nutrients to the central nervous system and clears metabolic waste products from brain tissue. A leak can produce multiple debilitating symptoms, including headaches that worsen when standing.

Millions of women in the United States receive neuraxial anesthesia during childbirth each year, and accidental dural puncture is a recognized complication that can result in persistent symptoms in a subset of patients, Callen said. "And that is only one source of CSF leaks. We still have remarkably little population-level data on spontaneous leaks, so the true burden of this disease remains poorly understood."

The transformative gift will also help grow the CSF Leak team with additional specialists "who can devote their whole self to this," Callen said. "With our staffing model, we're booked into mid-2027 right now. And these people are, as Jen says, staring at the ceiling and suffering in silence. That's unacceptable."

Parents instill patient-centered care

Callen grew up in California's Bay Area and is the son of doctors. His late father was a pioneer in obstetric ultrasound, writing the textbook "Callen's Ultrasonography in Obstetrics and Gynecology."

"He used to always say to me as I was coming up through training (at the University of California San Francisco School of Medicine), 'Don't go into academics … It's all this stuff on these numbers and measurements; it's not about the patient anymore,'" Callen said.

"I was like, 'Dad, what are you talking about? You base your whole career on this. You love your job.'"

Passionate, patient-centered care was clearly ingrained in the younger Callen. He regularly sees heavy psychological burdens being carried across painful, frustrating and time-consuming patient journeys. According to CU Anschutz researchers in collaboration with the Spinal CSF Leak Foundation, nearly 80% of patients reported being misdiagnosed and saw a median of more than six clinicians before receiving the correct diagnosis.

"They're sick. They need help. Not in their head, but in their spine," Callen said. "So they arrive at their appointment, and I just feel devastated for them because it reminds me of somebody who is accused of a crime they didn't commit."

A critical moment of the treatment, he said, is sitting with the patient and listening to their story – free of preconceived notions. It's not uncommon for patients to show him pictures of their lives pre-onset – running marathons, climbing mountains, traveling the world, caring for their families.

"It is therapeutic for someone to say, 'I believe you. I believe you, and I'm not a miracle worker. I can't guarantee I'm going to find something to fix you, but I believe you. There's something going on here. You're not crazy.'"

How doctors diagnosed Jen's complex CSF leak

For Jen, the crushing claustrophobia of her condition – the relentless pain, sensory dysfunction, cognitive fog and nausea – began to finally lift after she arrived in Aurora.

Callen diagnosed her as having an iatrogenic CSF leak, meaning it was caused by a medical procedure. Using a specialized MRI protocol designed for detecting subtle CSF leaks, he localized a "bleb" along her lumbar spine: a small outpouching of the dura characteristic of a prior needle injury – and in retrospect this had been present on her earliest MRIs. After discussing this finding with her, it was suspected that when given an epidural during labor with her first child, the needle accidentally poked through the dura, which surrounds and contains the CSF in the spine.

Unlike iatrogenic/doctor-caused CSF leaks, a spontaneous spinal CSF leak occurs without a preceding medical procedure or specific precipitating event.

There are three subtypes of spontaneous leak:

- a bone spur that pierces a hole in the front of the dura;

- a tear in the side of the dura, near where the nerve exits the spine;

- a CSF venous fistula, which is an abnormal connection between the normal space containing CSF within the dura and veins outside the dura. Venous fistulas weren't described until 2014 and require more research as they still aren't well understood.

A patch, then surgery

Jen's treatment began with a patch using fibrin glue, a sealant made from pooled donated human plasma that is distinctly different from a typical blood patch. "Every one of these procedures is really something different, depending on the type of leak they have," Callen said.

The patch procedure took place in December 2022, giving her immediate, though temporary, relief. Her family then traveled home to Seattle, where she finally settled back into the living room couch.

Jen had spent the last couple Christmases in her bedroom as her husband had set up cameras so she could see her family opening gifts. "We shared Christmas for the first time in years," she said, holding back tears.

In February 2023, Jen returned to CU Anschutz for surgery performed by Callen's neurosurgical partner and leak program co-director Peter Lennarson, MD, and the CSF Leak team. Using a minimally invasive surgical approach, Lennarson repaired the bleb.

"Once I was awake and had my full faculties back, I was feeling better," Jen said. "I knew it worked."

What recovery after CSF leak treatment can involve

She went through a "rebound intracranial hypertension" period where her symptoms fluctuated, and some new symptoms appeared, as her body re-accommodated to her new sealed state. It wasn't until September 2025 – 2-1/2 years after the surgery – that Jen began to drive again. "For so many people," she said, "recovery is a really curvy line with ups and downs, so you just need patience and compassion for yourself because it's very complicated."

Callen said it's common for CSF leak patients to experience rebound intracranial hypertension, which causes a different type of headache and other lingering symptoms, which can last days to months, or even longer in some cases. It's another area where the CSF Leak Program gift will help advance research, potentially leading to better treatments.

"That's another reason we felt we needed to have a clinic and a program, not just a procedure service," Callen said. "For patients who've been living with this for a long time, after closing the leak, they develop a sort of CSF disequilibrium state.